美国贸易代表办公室：美国与英国就药品定价达成原则性协议

Group 1 - The core point of the article is that the U.S. Trade Representative's office announced a principled agreement between the U.S. and the U.K. regarding drug pricing [1] Group 2 - The agreement signifies a collaborative effort between the two countries to address pharmaceutical pricing issues [1] - This development may have implications for the pharmaceutical industry, particularly in terms of pricing strategies and market access [1] - The agreement could potentially influence future negotiations and policies related to drug pricing on a global scale [1]